Virtual: Future Nostalgia: How We Got From Xylazine to Zenalpha and What It Means for Your Canine Patients

Virtual: Future Nostalgia: How We Got From Xylazine to Zenalpha and What It Means for Your Canine Patients

Streaming - Virtual
Anesthesiology

Information

This session is livestreamed from VMX Orlando. This session will review the clinical aspects of using alpha-2 adrenergic agonists in small animals and will introduce the audience to a new formulation of medetomidine. Key differences between the new formulation, Zenalpha, and other sedatives and tranquilizers will be highlighted, including indications, contraindications, and dosing recommendations. Sponsored By: Dechra
Primary Discipline
Small Animal
CE Credit
1

Location

Dechra Veterinary Products1041Dechra is committed to helping you care for animals. We do this by providing quality products and the very highest level of support. Our companion animal portfolio focuses on endocrinology, anesthesia/analgesia, oncology, dermatology, kidney health, ophthalmology, fluid therapy, anti-infectives, joint health, and dental care. Dechra’s key brands include Zenalpha® (medetomidine and vatinoxan hydrochlorides injection), Laverdia®-CA1 (verdinexor tablets), Vetoryl® Capsules (trilostane), Zycortal® Suspension (desoxycorticosterone pivalate injectable suspension), and Osurnia® (florfenicol, terbinafine, betamethasone acetate). Dechra’s rapid growth is fueled by these key products and others in the portfolio, as well as recent highly successful acquisitions, including Putney (2016), Piedmont (2022), and Med-Pharmex (2022). We continue to grow because we understand the challenges veterinarians face and we give them what they need. For more information, please visit www.dechra-us.com or call (866) 933-2472

Log in